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Vaccinia virus growth factor (VGF), a highly glycosylated polypeptide encoded in the genome of vaccinia virus, shares
amino acid sequence homology and functional properties with cellular growth factors, EGF and TGF-a. Although the
mitogenic activity of the purified or synthetic VGF suggested that the factor may be beneficial for viral replication by
stimulation of host cell growth, neither the role in virus life cycle nor the step next to the EGF receptor activation had been
firmly established. We found tyrosine-phosphorylations of PLC-g1 and a concomitant increase of the phosphoinositides
level in the human epidermoidal A431 cells either treated with purified VGF or infected with vaccinia virus. In contrast to
the wild-type virus, a VGF0 mutant virus did not induce tyrosine phosphorylation of PLC-g1. Phosphopeptide analysis
indicated that the phosphorylation of the PLC-g1 by VGF includes tyrosine residues identical to those phosphorylated by
EGF. These results suggest that tyrosine phosphorylation of PLC-g1, mediated by VGF, leads to activation of PLC-g1 and
a concomitant increase in phosphatidylinositol turnover. q 1995 Academic Press, Inc.
INTRODUCTION on the strong sequence homology to EGF and the mito-
genic activity of the purified or synthetic VGF (Stroobant
Molecular interactions associated with transduction of
et al., 1985; Twardzick et al., 1985). Implication has been
the extracellular signals and subsequent cellular re-
that the virus-encoded growth factor may be beneficial
sponses have been the subject of extensive studies. Vac-
to virus replication and spread by triggering the prolifera-cinia virus growth factor (VGF) provides an interesting
tion of host cells either already infected or present nearexample of such signals, as it is not only related in struc-
the infected cell.ture to the epidermal growth factor (EGF) and trans-
VGF is produced in the early phase of the virus replica-forming growth factor (TGF)-a (Blomquist et al., 1984;
tion cycle and secreted into the extracellular medium.Brown et al., 1985), but also encoded in the genome of
The secreted VGF consists of 77 amino acids (derivedan infectious virus which upon infection induces host
from the precursor of 140 amino acids) and is substan-cells to undergo complex morphological and biochemical
tially glycosylated. Like EGF and TGF-a, VGF binds andchanges.
induces tyrosine phosphorylation of the EGF receptorVaccinia virus is a prototype member of the family
(Stroobant et al., 1985; King et al., 1986).poxviridae, which contains a linear double-strand DNA
Growth-factor activated EGF receptor phosphorylatesgenome of 190 kilobase pairs with the potential of encod-
the tyrosine residues of numerous intracellular proteinsing nearly 200 gene products and replicates in the cyto-
associated with cell proliferation process (Ushiro andplasm of a wide range of host cells. Although other mem-
Cohen, 1980; Carpenter, 1987). Several reports havebers of poxvirus, such as Yaba tumor virus and Shope
demonstrated that PLC-g1 is one of the prime targets offibroma virus, may induce host cell to form tumors, vac-
EGF receptor tyrosine kinase and the phosphorylation ofcinia virus is not considered as a transforming virus and
PLC-g1 results in turnover of phosphoinositides, whichgenerally induces profound changes on host cell struc-
in turn induces cellular Ca2/ influx and cell proliferationture and metabolism, which eventually leads to cell death
(Meisenhelder et al., 1989; Smith et al., 1989; Valius and(reviewed by Moss, 1990).
Kazlauskas, 1993; Noh et al., 1994; Park et al., 1994).Among various effects of this cytocidal virus on host
Growing number of studies also suggest that arachido-cell are the hyperplastic responses of cells near or at
nyl-specific phospholipase A2 (PLA2) plays importantthe edge of growing lesion during active viral replication,
role(s) in EGF-activated pathway (Spaargaren et al., 1992;which often appears under microscope as a bright ring
Lin et al., 1992). PLA2 hydrolyzes arachidonic acids fromaround plaques. This effect was attributed to VGF, based
membrane phospholipids. Activation of PLA2, probably
by mitogen-activated protein (MAP) kinase, results in the1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 82-562-279-2199. production of a number of arachidonic acid metabolites
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such as prostaglandins and leukotriens which regulate PLC-g1 (Suh et al., 1988), goat anti-mouse IgG (ICN Bio-
chemicals), and formalin-fixed Staphylococcus aureusa variety of cellular responses (Peppelenbosch et al.,
1993). (Calbiochem) as previously described (Meisenhelder et
al., 1989). After washing, the immunoprecipitated pro-Since the discovery of VGF, several studies have been
performed using either purified or chemically synthe- teins were released by heating at 957 for 2 min in loading
buffer and separated by electrophoresis on 8% SDS–sized VGF to demonstrate the EGF-like activity of cell
proliferation. This was mainly due to the cytolytic nature polyacrylamide gels (Laemmli, 1970). Proteins separated
by electrophoresis were transferred onto nitrocelluloseof vaccinia virus that generally obscures the mitogenic
effect of VGF. Although these studies clearly demon- membranes and blotted with anti-PLC-g1 antibodies or
anti-phosphotyrosine antibody 4G10 (Upstate Biotech-strated the phosphorylation of the cellular EGF receptor
by purified VGF or by vaccinia virus infection, it was not nology Inc.). The immune complex was detected with
alkaline phosphatase-conjugated goat anti-mouse Igfirmly established whether this effect is directly from the
VGF expressed during viral replication or simply reflects system (Kirkegarrd and Perry Lab).
the complex influence of the virus on host metabolism.
Determination of Inositol phosphatesAlso not known was the events downstream of the EGF
receptor activation. Cells were incubated with myo-[3H]inositol (2 mCi/ml)
In this report we addressed these issues by using (Amersham) for 24 hr in inositol-free DMEM supple-
wild-type virus and a VGF0 deletion mutant in the exami- mented with 0.5% dialyzed fetal bovine serum and were
nation of the PLC-g1, a well characterized target of the infected with vaccinia virus for the time indicated. Infec-
EGF receptor kinase. We found a significant increase in tion was terminated by aspiration of the media and inosi-
the phospho-tyrosine level of the PLC-g1 and a concomi- tol phosphates were extracted for 30 min with 600 ml of
tant increase in free inositol phosphates during infection ice-cold 5% perchloric acid. The acid soluble fraction
by the wild-type virus but not by the VGF0 mutant virus. was diluted fivefold with distilled water and applied to a
Furthermore, using purified VGF we also demonstrated Dowex AG 1X-8 anion-exchange column (Bio-Rad). After
that the phosphorylated tyrosine residues of the PLC-g1 washing the column with 60 mM ammonium formate/5
by the VGF is identical to those by the EGF. mM sodium tetraborate, inositol phosphates were eluted
with 1.0 M ammonium formate/0.1 M formic acid and
MATERIALS AND METHODS determined as described (Margolis et al., 1990).
Cells and viruses Purification of VGF
A431 cells and NIH 3T3 2.2 cells were grown at 377 HeLa S3 cells (2 1 109) cultured in 5 liters of SMEM
in Dulbecco’s modified Eagle’s medium (DMEM) supple- were harvested and infected with 20 PFU of vaccinia
mented with 10% fetal bovine serum. HeLa S3 cells were virus per cell in 200 ml medium for 1 hr. After adsorption,
grown in suspension in spinner minimum essential me- virus cells were washed and incubated in serum-free
dium (SMEM) containing 5% horse serum. Culture media SMEM for an additional 24 hr. The culture medium was
and sera were purchased from Life Technologies, Inc. collected and acetic acid was added to the final concen-
Wild-type (strain WR) and VGF0 deletion mutant (Buller tration of 0.2 M. After removal of insoluble material super-
et al., 1988) vaccinia virus were kindly provided by Dr. natant was lyophilized and resuspended in 1 M acetic
Bernard Moss (National Institutes of Health) and propa- acid and dialyzed against 0.2 M acetic acid. The dialysate
gated as described (Earl et al., 1991). was concentrated by ultrafiltration (Amicon) and dialyzed
against 50 mM Tris–HCl (pH 7.4) containing 1 mM CaCl2
Virus infection and PLC-g1 analysis and MnSO4 . The sample was applied to a ConA-Sepha-
rose column (Pharmacia) and proteins were eluted withA431 cells or NIH 3T3 2.2 cells, grown to about 70%
10 mM methyl-mannopyranoside. The eluate was con-confluency in 100-mm culture dishes, were infected with
centrated and dialyzed against 50 mM Tris–HCl (pH 7.4)vaccinia virus at the conditions indicated. The infection
and applied to the TSKgel G3000SW column (Tosoh,was terminated by aspiration of the media and cells were
Tokyo; 0.751 60 cm). Proteins in fractions were analyzedwashed twice with ice-cold phosphate-buffered saline.
by immunoblotting with rabbit anti-EGF antibody (UpstateCells were lysed in 1 ml of ice-cold lysis buffer (20 mM
Biotechnology Inc.).HEPES, pH 7.2, 1% Triton X-100, 10% glycerol, 50 mM
NaF, 1 mM phenylmethylsulfonyl fluoride, 1 mM Na3VO4 , Growth factor treatment
10 mg/ml leupeptin) for 30 min on ice-bath and cell debris
were removed by centrifugation for 20 min at 47 in a A431 cells or NIH 3T3 2.2 cells, grown to about 70%
confluency in 100-mm culture dishes, were washed twicemicrofuge.
Immunoprecipitation of PLC-g1 in cell lysates was per- with serum-free DMEM and further incubated for 24
hours in the serum-free medium. Cells were preincu-formed with a mixture of six monoclonal antibodies to
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bated with 0.1 mM Na3VO4 for 15 min and then incubated
with purified VGF or EGF for the time indicated. Growth
factor treatment was terminated by aspiration of the me-
dia. After washed twice with ice-cold phosphate-buffered
saline, cells were lysed in a ice-cold lysis buffer and the
PLC-g1 was analyzed as in Fig. 1.
For labeling, the cells were incubated with 0.5 mCi/
ml of [32P]orthophosphate (Amersham) in phosphate-free,
serum-free DMEM for 4 hr before growth factor treat-
ment. Lysate was prepared from the growth factor-
treated cell and the 32P-labeled PLC-g1 was immunopre-
cipitated using monoclonal anti-PLC-g1 antibodies. After
SDS–PAGE, gel was dried and subjected to autoradiog-
raphy.
FIG. 1. Tyrosine phosphorylation of PLC-g1 by vaccinia virus infec-
tion. A431 cells grown to 70% confluency in 100-mm dishes were in-Tryptic phosphopeptide analysis
fected with vaccinia virus at various m.o.i. for 18 hr (A) or at the m.o.i.
of 50 for various time (B). At the end of infection cell lysate was preparedAfter being visualized by autoradiography, the poly-
and PLC-g1 was immunoprecipitated by monoclonal antibodies to PLC-acrylamide gel slice containing 32P-labeled PLC-g1 was
g1 from cell lysates containing approximately 1 mg of protein. Thecut out and the proteins were trypsinized as described
immunecomplex was separated by 8% SDS–polyacrylamide gels,
(Park et al., 1991). Resulting phosphopeptides were sep- transferred onto nitrocellulose membranes, and incubated with anti-
arated in two dimensions on a 0.1-mm thin layer cellulose phosphotyrosine antibodies followed by alkaline phosphatase-conju-
gated goat anti-mouse Ig. The position of PLC-g1 is indicated by theplate. First, electrophoresis was done for 30 min at 1 kV
arrows.in the buffer consisting of acetic acid/88% formic acid/
water (156:50:1794, v/v) in a Hunter apparatus (American
Hi-Tech Co.). Second, chromatography was performed
with m.o.i., whereas a control immunoblot with anti-PLC-in n-butanol:pyridine:acetic acid:water (75:50:15:60, v/v).
g1 antibody showed that the overall amount of PLC-g1The plates were then dried and exposed to Kodak X-ray
protein level remained constant (data not shown).film.
Phosphorylation of the PLC-g1 increased during the
course of viral infection with the level peaked on or later
RESULTS than 15 hr postinfection (Fig. 1B). Although the VGF gene
is thought to be early class gene, this pattern of responseActivation of PLC-g1 by vaccinia virus
is consistent with the previous results that the VGF pro-
Previous studies had shown that the purified VGF stim- tein in the culture medium was increased in late time of
ulates phosphorylation of EGF receptor on tyrosine resi- infection (Twardzik et al., 1985).
dues (Stroobant et al., 1985). Although a similar modifica-
tion of the EGF receptor was observed during vaccinia Tyrosine phosphorylation of vaccinia virus
virus infection (King et al., 1986), it was not confirmed
whether this activity was directly provided by the VGF To elucidate the role of VGF in the PLC-g1 stimulation
during virus infection, we performed a comparative analy-expressed during the course of virus replication. Also
not known is the events downstream of the EGF receptor sis between the wild-type vaccinia virus (strain WR) and
its deletion mutant vSC20, which has both copies of theactivation.
Since the PLC-g1 was known to be one of the key VGF gene replaced by LacZ-gene casettes (Buller et al.,
1988). In contrast to the wild-type virus, infection of A431mediators of the EGF receptor-mediated signal (Meisen-
helder et al., 1989), we wanted to know if this is the cells with the vSC20 did not show any tyrosine phosphor-
ylation (Fig. 2). Although the immunoblot showed pres-case for the vaccinia virus. The A431, human epidermoid
carcinoma cells, known for the abundance of EGF recep- ence of few other proteins which seemed to cross-react
with the antibodies used, the identity of the tyrosinetors (Fabricant et al., 1977), were infected with vaccinia
virus and the PLC-g1 was separated from cell lysates phosphorylation of PLC-g1 induced by the wild-type vac-
cinia virus was confirmed by the migration position inby immunoprecipitation with monoclonal anti-PLC-g1 an-
tibodies. The immune complex was further analyzed by SDS–PAGE (approximately 160 kDa in molecular mass)
and reaction of the duplicate immunoblot with anti-PLC-anti-phosphotyrosine antibody after SDS–PAGE. As
shown in Fig. 1A, infection of A431 cells with vaccinia g1 antibody (lower panel). The latter immunoblot also
served as a control to show that the level of PLC-g1virus at m.o.i. as low as 5 PFU per cell induced a signifi-
cant level of phosphotyrosine of the PLC-g1. The amount proteins remained constant in either uninfected cells or
cells infected with either of the two viruses. Lack of theof the tyrosine-phosphorylated PLC-g1 was correlated
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show any increase of the free inositol phosphates over
the background level. These results clearly demon-
strated that the accumulation of intracellular inositol
phosphates level is the consequence of the VGF-medi-
ated PLC-g1 activation.
Tyrosine phosphorylation by VGF, EGF, and PDGF
To further characterize the stimulatory activity of VGF
we purified VGF to near homogeneity from the culture
supernatant of vaccinia virus-infected cells (data not
shown). As was previously shown, the purified protein
migrated in SDS–PAGE to the position of approximately
24 kDa in size, indicative of complete processing and
glycosylation (Stroobant et al., 1985; Twardzik et al., 1985;
Chang et al., 1988). Further identification of the purified
VGF was done by immunoblotting with polyclonal anti-
mouse EGF antibodies as described previously (Reisner,
1985). With purified VGF in hands we first tried to exam-
ine whether the VGF activates PLC-g1 in a manner simi-
FIG. 2. Effect of VGF0 mutant virus on the PLC-g1 phosphorylation.
A431 cells were infected with either wild-type or VGF0 mutant virus at
m.o.i. of 50. The tyrosine phosphorylation of the PLC-g1 was analyzed
as described in the legend of Fig. 1 (upper panel). A duplicate immu-
noblot was performed using anti-PLC antibodies instead of anti-phos-
photyrosine antibody (lower panel).
tyrosine-phosphorylated PLC-g1 in the cells infected with
the VGF0 mutant virus, even at high m.o.i., strongly indi-
cates that the tyrosine phosphorylation of PLC-g1 is spe-
cifically mediated by the VGF produced during viral infec-
tion.
Inositol phosphates turnover vaccinia virus
To examine the effect of PLC-g1 phosphorylation, virus
infected cells were examined for the level of inositol
phosphates. PLC-g1 hydrolyzes phosphatidylinositol 4,5-
bisphosphate to produce two intracellular second mes-
senger molecules, namely, inositol 1,4,5-trisphosphate
and 1,2-diacylglycerol. To quantitate the inositol phos-
phates, A431 cells were metabolically labeled with [3H]-
myo-inositol starting from 24 hr before the virus infection.
The intracellular level of free inositol phosphates was
measured during vaccinia virus infection. As shown in
Fig. 3, only the cells infected with wild-type virus resulted
in the increase of intracellular inositol phosphates. The
level of inositol phosphates was increased by approxi-
FIG. 3. Accumulation of inositol phosphates in virus-infected cells.mately 50% at m.o.i. of 5 and reached up to 2.7 times the
A431 cells, labeled with myo-[3H]-inositol (2 mCi/ml) for 24 hr in inositol-background level at higher m.o.i. (Fig. 3A). This pattern
free media, were infected with either wild-type or VGF0 mutant viruswas consistent with that of PLC-g1 phosphorylation. A
at various m.o.i. for 18 hr (A) or at m.o.i. of 50 for various time (B). Cells
similar increase was observed at late time of virus infec- were lysed and inositol phosphates were measured as described under
tion with the peak at 15 hr of postinfection (Fig. 3B). In Materials and Methods. Averages of triplicate determinations (mean
{ S.D.) are shown.contrast to the wild-type virus, infection of vSC20 did not
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phosphorylation of PLC-g1 by VGF-stimulated EGF re-
ceptor tyrosine kinase enhances cellular phosphoinosi-
tide breakdown, an effect similarly observed by vaccinia
virus infection.
Phosphopeptide analysis of tyrosine-phosphorylated
PLC-g1
We wanted to know whether the sites of VGF-mediated
PLC-g1 phosphorylation are identical to those phosphor-
ylated by EGF. After the A431 cells were incubated for 4
hr with [32P]orthophosphate, purified VGF or an equiva-
lent amount of EGF was added. Cells were then collected
and PLC-g1 was immunoprecipitated from cell lysates
using monoclonal anti-PLC-g1 antibodies. Within 5 min
after the VGF treatment, the level of tyrosine phosphoryla-
tion of PLC-g1 increased about fivefold over the basal
level (cells without VGF treatment) (Fig. 7). Although the
intensity of the phosphorylation by VGF was somewhat
lower than that by EGF, the immediate increase of the
FIG. 4. PLC-g1 phosphorylation by purified VGF in A431 cells (A) but phosphorylation of PLC-g1 to a substantial amount sug-
not in NIH 3T3 2.2 cells (B). Cells were stimulated with VGF (2 mg/ml), gested a VGF-specific response. Two unidentified pro-
EGF (100 ng/ml), or PDGF (30 ng/ml), respectively, for 5 min at 377, as teins, ranging in size approximately from 68 to 90 kDa,
indicated on the top of each lane. Positions of PLC-g1 are indicated
appeared in all lanes, including the control cell lysateon the left.
without the stimulation of the growth factors. These pro-
teins may simply cross-react with the PLC-g1 antibody
lar to EGF and PDGF. As shown in Fig. 4A, a rapid in- or they may be physically associated with the PLC-g1
crease of the tyrosine phosphorylation of PLC-g1 was and thereby coprecipitated by anti-PLC-g1 antibodies.
achieved by VGF treatment. The induction level was com- To analyze the [32P]phosphopeptides the phosphory-
parable to that by EGF, although 20 times more VGF was
used in this experiment. The difference would probably
be due to the purity of VGF rather than the affinity of the
two effector molecules.
The stimulating activity of VGF for PLC-g1 was cell
specific as in the case of the NIH 3T3 2.2 cells which
did not show any increase of tyrosine phosphorylation
of PLC-g1 (Fig. 4B), whereas a strong stimulation of PLC-
g1 was observed by PDGF. The abundance of PDGF
receptor but lack of EGF receptor on the surface of the
NIH 3T3 2.2 cell accounts for the specific response.
VGF-stimulated tyrosine-phosphorylation of PLC-g1
showed a typical ligand receptor response in that the
increase in phospho-tyrosine content of the PLC-g1 was
evident immediately (within minutes) after the VGF treat-
ment and the response disappeared in less than 30 min
(Fig. 5A). A significant level of tyrosine phosphorylation
of PLC-g1 was induced by VGF as low as 5 mg/ml (proba-
bly 2 mg/ml would show a similar effect as shown in Fig.
4A) and the response was saturated up to 20 mg/ml of
VGF (Fig. 5B). These results suggest that tyrosine phos-
phorylation of PLC-g1 in A431 cells was specifically me-
FIG. 5. Tyrosine phosphorylation of PLC-g1 in A431 cells. Cells werediated by VGF-stimulated EGF receptor tyrosine kinase.
treated with purified VGF (5 mg/ml) for various times (A) or with variousThe amount of cellular inositol phosphates increased
concentrations of VGF for 5 min (B). PLC-g1 was analyzed by immu-about fourfold by treatment with VGF for 30 min (Fig. 6A).
noblotting with anti-phosphotyrosine antibody as described in the leg-
The level of cellular inositol phosphates by VGF increase end of Fig. 1. The positions of prestained molecular weight markers
was comparable to that by EGF, although much less EGF are indicated on the right and the position of PLC-g1 is indicated on
the left.was needed for the response (Fig. 6B). Thus, tyrosine
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FIG. 7. Phosphorylation of PLC-g1 by VGF and EGF treatment. Immu-
noprecipitation of 32P-labeled PLC-g1 from the lysate of A431 cells
treated for 5 min with VGF (2 mg/ml), EGF (100 ng/ml) or no growth
factor (0), respectively. After 7.5% SDS–polyacrylamide gel electropho-
resis, gels were dried and exposed to X-ray film for 3 hr at 0707. The
position of the PLC-g1 is indicated by an arrow.
sized VGF to demonstrate the EGF-like activity of cell
proliferation. This was mainly due to the cytolytic nature
of vaccinia virus which generally obscures the mitogenic
effect of VGF. Although these studies clearly demon-FIG. 6. Accumulation of inositol phosphates in growth-factor-treated
cells. A431 cells, labeled with myo-[3H]-inositol (2 mCi/ml) for 24 hr in strated the phosphorylation of the cellular EGF receptor
inositol-free media, were treated with various concentrations of VGF by purified VGF or by vaccinia virus infection, it was not
(A) or EGF (B) for 30 min at 377. Cells were lysed and inositol phos-
phates were measured as described under Materials and Methods.
Averages of duplicate determinations (mean { S.D.) are shown.
lated PLC-g1 was separated from the denaturing poly-
acrylamide gel and after tryptic digestion the resultant
peptides were analyzed in two dimension by electropho-
resis and chromatography. PLC-g1 isolated from un-
treated A431 cells gave rise to two major phosphoserine-
containing peptides, designated as 1 and 3 (Fig. 8A).
Phosphopeptides of PLC-g1 from VGF- or EGF-treated
cell yielded additional spots, designated as a, b, and c
(Figs. 8B and 8C, respectively). Except the slightly weaker
intensity of the spot b from EGF-treated cell, identical
pattern was obtained from VGF- and EGF-treated cells.
It was previously reported that EGF receptor tyrosine
kinase phosphorylates PLC-g1 on tyrosine residues 771,
783, and 1254, and phosphorylation of the residues 783
FIG. 8. Two-dimensional tryptic phosphopeptide maps of PLC-g1.and 1254 is essential for growth factor-dependent activa-
32P-labeled PLC-g1, from A431 cells treated with VGF or EGF, wastion of PLC-g1 (Kim et al., 1991). These results clearly
separated by immunoprecipitation and SDS–PAGE. After an autoradi-demonstrate that the PLC-g1 activation by VGF and EGF
ography was done, PLC-g1 was extracted from the gel slices, digested
are mediated by the common EGF receptor kinase. with trypsin, and the fragments were separated in the first dimensions
(horizontal) by high-voltage electrophoresis and in the second dimen-
sions (vertical) by thin-layer chromatography. Phosphopeptides fromDISCUSSION
control cell (A), from VGF- (B), and EGF- (C) treated cells, and the
Since the discovery of VGF several studies have been positions of peptides containing phosphorylated residues are marked
(D). Arrows indicate the positions of sample applications.performed using either purified or chemically synthe-
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confirmed whether this effect is directly from the VGF of EGF into the culture medium. Although Ca2/ influx
associated with virus infection may be general conse-expressed during viral replication or simply reflects the
complex influence of the virus on host metabolism. Also quences of viral binding to cell receptor or infection cycle
that follows, our results show a first example of receptor-not known was the events downstream of the EGF recep-
tor activation. activated pathway mediated by a specific catalytic pro-
tein which leads to the increase of intracellular Ca2/.We addressed these issues by using wild-type virus
and a VGF0 deletion mutant in the examination of the The profound changes in the integrity of cellular microfil-
aments and membranes, induced by VGF-mediated Ca2/PLC-g1, a well characterized target of the EGF receptor
kinase. We found a significant increase of the tyrosine influx, may be beneficial for virus adsorption and entry.
Alternative pathway leading to the EGF receptor-medi-phosphorylation of the PLC-g1 during the infection by
the wild-type vaccinia virus but not by the VGF0 mutant ated cellular Ca2/ influx can be mediated by phospholi-
pase A2. PLA2 in many cells was known to be activatedvirus. Consistent with this result we found a substantial
accumulation of the free inositol phosphates only in the as a result of EGF receptor stimulation, probably via MAP
kinase (Lin et al., 1992). Activation of PLA2 results in thecells infected with wild-type virus. Furthermore, using
purified VGF, we showed that the pattern of tyrosine release of arachidonic acid from membrane phospholip-
ids that is then converted by 5-lipoxygenase into a num-phosphorylation of the PLC-g1 by the VGF is identical to
that by EGF. Thus, we extended previous findings of EGF ber of metabolites such as leukotrienes. Peppelenbosch
et al. (1993) suggested that the arachidonate metabolitesreceptor activation by VGF a step further, showing that
the VGF-mediated pathway involves PLC-g1 and that play an important role in EGF-mediated cytoskeletal pro-
tein function modulations, such as cortical actin reorgani-PLC-g1 is activated by the phosphorylation of critical
tyrosine residues. zation and stress fiber breakdown, although these pro-
cesses may also be related to an alteration of the phos-Although ours and other investigators results strongly
support the growth-stimulatory property of VGF, which phoinosides bound to actin-binding proteins (profilin or
gelsolin, etc.). In fact, enhanced level of arachidonatewould be beneficial for viral replication and spread, the
role of VGF in virus life cycle is still unclear. Isolation of metabolite had been observed in vaccinia virus infection,
although similar results obtained with VGF0 mutant indi-the VGF0 virus indicates that the factor is not essential
for the virus to be replicating in cultured cells, although cates that VGF is not directly involved in this process
(Palumbo et al., 1993).the mutant virus replicated less efficiently than wild-type
virus in resting cells as well as in mice and in rabbits Probably, several independent pathways may be in-
volved in cellular morphological change induced by virus(Buller et al., 1988). The use of VGF0 vaccinia virus also
provided an evidence against the role of VGF receptor infection. One of the pathways may be the VGF-mediated
activation of PLC-g1 and subsequent increase in cellularas a potential target for virus entry (Hugin and Hauser,
1994). The latter study showed that the NIH 3T3 2.2 cells inositol phosphates.
which stably expressed human PDGF receptor but not
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